title: [Prostate cancer and acute disseminated intravascular coagulation. Therapeutic management based on three cases].
abstract: Acute DIC is a rare, but life-threatening complication of metastatic prostate cancer. The authors discuss the treatment modalities in the light of three cases and a review of the recent literature. The key to treatment of DIC is treatment anti of the tumour. Androgen blockade is indicated in hormone-dependent tumours. This treatment can sometimes be completed by low-dose oral anticoagulants. Chemotherapy is the treatment of choice of acute DIC during the hormone resistance phase.
authors.affiliation: Service d'Urologie-Andrologie, Hôpital Gaston Doumergue, 5, rue Hoche, 30000 Nîmes, France. christophe.avances@wanadoo.fr
authors.forename: Christophe
authors.initials: C
authors.lastname: Avances
authors.forename: Chokri
authors.initials: C
authors.lastname: Oumaya
authors.forename: Victoire
authors.initials: V
authors.lastname: Granger
authors.forename: Olivier
authors.initials: O
authors.lastname: Dubon
authors.forename: Jean Christophe
authors.initials: JC
authors.lastname: Gris
authors.forename: Stéphane
authors.initials: S
authors.lastname: Culine
authors.forename: Pierre
authors.initials: P
authors.lastname: Costa
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000209:etiology*; D017809:Fatal Outcome; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D005343:Fibrinolytic Agents